Mechanisms involved in the increased vascular resistance in hypertension
1993; Wiley; Volume: 13; Issue: 2 Linguagem: Inglês
10.1111/j.1474-8673.1993.tb00264.x
ISSN1365-2680
Autores Tópico(s)Eicosanoids and Hypertension Pharmacology
ResumoJournal of Autonomic PharmacologyVolume 13, Issue 2 p. 127-176 Mechanisms involved in the increased vascular resistance in hypertension Jesús Marín, Jesús Marín Departamento de Farmacologia, Facultad de Medicina, Universidad Autónoma, C/Arzobispo Morcillo 4, 28029-Madrid, SpainSearch for more papers by this author Jesús Marín, Jesús Marín Departamento de Farmacologia, Facultad de Medicina, Universidad Autónoma, C/Arzobispo Morcillo 4, 28029-Madrid, SpainSearch for more papers by this author First published: April 1993 https://doi.org/10.1111/j.1474-8673.1993.tb00264.xCitations: 29AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References Aalkjaer, C. (1990). Regulation of intracellular pH and its role in vascular smooth muscle function. J. Hypertens., 8, 197–206. Aalkjaer, C., Haegerty, A. M., Petersen, K. K., Swales, J. D. and Mulvany, M. J. (1987). Evidence for increased media thickness, increased neuronal amine uptake and depressed excitation-contraction coupling in isolated resistance vessels from essential hypertensives. Cir. Res., 61, 181–186. Abbott, A. (1988). Interrelationship between Na+ and Ca+ metabolism in hypertension. Trends Pharmacol. Sci., 9, 111–113. Abdel-Latif, A. (1986). Calcium-mobilizing receptors, polyphosphoinositides, and the generation of second messengers. Pharmacol. Rev., 38, 227–272. Acceto, R. and Weder, A. B. (1987). Parathyroid hormone and verapamil inhibit the Na+, K+ pump in human erythrocytes. Clin. Res., 35, 437A. Admiraal, P. J. J., Derkx, F. H. M., Danser, A. H. J., Pieterman, H. and Schalekamp, M. A. D. H. (1990). Metabolism and production of angiotensin I in different vascular beds in subjects with hypertension. Hypertension, 15, 44–55. Alhenc-Gélas, F., Soubrier, F., Hubert, Mechanisms C., Allegrini, J. and Corvol, P. (1989). The characteristics of the amino acid sequence of angiotensin I-converting enzyme, as determined by cDNA cloning of the human endothelial enzyme. J. Cardiovasc. Pharmacol., 14 (Suppl. 4), S6–S9. Alonso, M. J., Salaices, M., Sanchez-Ferrer, C. F. and Marin, J. (1992). Predominant role for nitric oxide in the relaxations induced by acetylcholine in cat cerebral arteries. J. Pharmacol. Exp. Ther., 261, 12–21. Ambresioni, E., Costa, F. V., Montebugnoli, L., Tartagni, F. and Magnani, B. (1981). Increased intralymphocytic sodium content in essential hypertension: an index of an impaired sodium cellular metabolism. Clin. Sci., 61, 181–186. Amman, F. W., Bolli, P., Kiowsiu, W. and Bühler, F. R. (1981). Enhanced alpha-adrenoceptor-mediated vasoconstriction in essential hypertension. Hypertension, 3 (Suppl. I), 119–123. Anavekar, S. N., Cristophidis, N., Louis, W. J. and Doyle, A. E. (1981). Verapamil in the treatment of hypertension. J. Cardiovasc. Pharmacol., 3, 287–291. Angus, J. A. and Cocks, T. M. (1989). Endothelium-derived relaxing factor. Pharmacol. Ther., 41, 303–351. Antonaccio, M. J. (1982). Angiotensin converting enzyme (ACE) inhibitors. Ann. Rev. Pharmacol. Tox., 22, 57–87. Antonaccio, M. J. and Wright, J. J. (1990). Renin-angiotensin system, converting enzyme, and renin inhibitors. In: Cardiovascular Pharmacology, pp. 201–228. Ed. M. J. Antonaccio. Raven Press, New York . AokI, K. (1984). Essential hypertension and secondary hypertension in humans and rats. Prog. Clin. Med., 28, 529–548. Aoki, K. and Asano, M. (1986). Effects of Bay K 8644 and nifedipine on femoral arteries of spontaneously hypertensive rats. Br. J. Pharmacol., 88, 221–230. Aoki, Y., Yamashita, K., Tomita, N., Tayami, K. and Hotta, K. (1974). ATPase activity and Ca++ binding activity of subcellular membranes of arterial smooth muscle in spontaneously hypertensive rat. Jpn. Heart J., 15, 180–181. Arendshorst, W. J. (1979). Autoregulation of renal blood flow in spontaneously hypertensive rats. Cir. Res., 44, 344–349. Asano, M., Aoki, K. and Matsuda, T. (1982). Reduced beta-adrenoceptor interaction of norepinephrine enhanced contraction in the femoral artery from spontaneously hypertensive rats. J. Pharmacol. Exp. Ther., 233, 207–214. Ashida, T., Kuramochi, M. and Omae, T. (1989). Increased sodium-calcium exchange in arterial smooth muscle of spontaneously hypertensive rats. Hypertension, 13, 890–895. Assender, J. W., Southgate, K. M. and Newby, A. C. (1991). Does nitric oxide inhibit smooth muscle proliferation J. Cardiovasc. Pharmacol., 17 (Suppl. 3). S104–S107. Atkinson, J., Sautel, M., Sonnay, M., Fluckiger, J.-P., DeRivaz, J.-C., Boillat, N., Piton, M.-C., Porchet, P.-A., Amarstrong, J. M. and Fouda, A.-K. (1988). Greater vasodepressor sensitivity to nicardipine in spontaneously hypertensive rats (SHR) compared to normotensive rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 337, 471–476. Auch-Schwelk, W., Katusic, Z. S. and Vanhoutte, P. M. (1990). Thromboxane A2-receptor antagonists inhibit endothelium-dependent contractions. Hypertension, 15, 699–703. Aurbach, G. D., Marx, S. J. and Sepigel, A. M. (1981). Parathyroid hormone, calcitonin, and the calciferols. In: Textbook of Endocrinology, pp. 922–1031. Ed. R. H. Williams. W. B. Saunders, Philadelphia . Aviv, A. and Lasker, N. (1990). Proposed defects in membrane transport and intracellular ions as pathogenic factors in essential hypertension. In: Hypertension: Pathophysiology, Diagnosis, and Management, pp. 923–937. Eds J. H. Laragh and B. M. Brenner. Raven Press, New York . Azar, S., Johnson, M. A., Sheinman, J., Buruno, L. and Tobian, L. (1979). Regulation of glomerular capillary pressure and filtration rate in young Kyoto hypertensive rats. Clin. Sci., 56, 203–209. Bachmann, S., Peters, J., Engler, E., Ganten, D. and Moullins, J. J. (1992). Transgenic rats carrying the mouse renin gene-Morphological characterization of a lowrenin hypertension. Kidney Int., 41, 24–36. Baker, P. F., Blaustein, M. P., Hodgkin, A. L. and Steinhardt, R. A. (1969). The influence of calcium on sodium efflux in squid axons. J. Physiol., 200, 431–438. Becker, R. H. A., Linz, W. and Scholkens, B. A. (1989). Pharmacological interference with the cardiac renin-angiotensin system. J. Cardiovasc. Pharmacol., 14 (Suppl. 4), S10–S15. Belizan, J. M. and Villar, J. (1983). Reduction of blood pressure with calcium supplementation in young adults. JAMA, 249, 1161–1165. Bellin, L. J., Wade, D. N., Honour, A. J. and Cole, T. J. (1970). Vascular hyperactivity with sodium loading and with deoxycorticosterone induced hypertension in the rat. Clin.Sci., 39, 793–810. Berk, B. C., Vallega, G., Muslin, A. J., Gordon, H. M., Canessa, M. and Alexander, R. W. (1989). Spontaneously hypertensive rat vascular smooth muscle cells in culture exhibit increased growth and Na+/H+exchange. J. Clin. Invest., 83, 822–829. Berridge, M. J. (1986). Inositol trisphosphate and calcium mobilization. J. Cardiovasc. Pharmacol., 8 (Suppl. 8), S85–S90. Berridge, M. J. (1987). Inositol trisphosphate and diacylglycerol: two interacting second messengers. Ann. Rev. Biochem., 56, 159–163. Bertel, O., Bohler, F. R., Kiowski, W. and Lutold, B. D. (1980). Decreased beta-adrenoceptor responsiveness as related to age, blood pressure, and plasma catecholamines in patients with essential hypertension. Hypertension, 2, 130–138. Bevan, R. D. (1984). Trophic effects of peripheral adrenergic nerves on vascular structure. Hypertension, 6 (Suppl. III), III19–III26. Bevan, J. A., Bevan, R. D., HWA, J. J., OWEN, M. P. and TAYO, F. M. (1986). Calcium regulation in vascular smooth muscle: is there a pattern to its variability within the arterial tree J. Cardiovasc. Pharmacol., 8 (Suppl. 8), 71–75. Bhalla, R. C., Webb, R. C., Ashley, T. and Brock, T. (1978). Calcium fluxes, calcium binding and adenosine 3|M',5|M'-monophosphate dependent protein kinase activity in aorta of spontaneously hypertensive and Wistar nor-motensive rats. Mol. Pharmacol., 14, 468–477. Bindels, R. J. M., Van Den Brock, L. A. M., Jongen, M. J. M., Hackeng, W. H. L., Lowik, C. W. G. M. and Van OS, C. H. (1987). Increased plasma calcitonin levels in young spontaneously hypertensive rats: role in disturbed phosphate homeostasis. Pflügers Arch., 408, 395–400. Blaustein, M. P. (1977). Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am. J. Physiol., 232, C165–C173. Blaustein, M. P. and Hamyln, J. M. (1984). Sodium transport inhibition, cell calcium, and hypertension: the natriuretic hormone/ Na+-Ca2+ exchange/hypertension hypothesis. Am. J. Med., 77, 45–59. Bogen, E., Massry, S. G., Levi, J., Djaldeti, M., Bristol, G. and Smith, J. (1982). Effect of parathyroid hormone on osmotic fragility of human erythrocytes. J. Clin. Invest., 69, 1017–1025. Bohr, D. F. (1963). Vascular smooth muscle: dual effect of calcium. Science, 139, 597–599. Bohr, D. F. and Webb, R. C. (1984). Vascular smooth muscle function and its changes in hypertension. Am. J. Med., 77, 3–16. Bolger, G. T., Liard, F., Jodoin, A. and Jaramillo, J. (1991). Vascular reactivity, tissue levels, and binding sites for endothelin: a comparison in the spontaneously hypertensive and Wistar-Kyoto rats. Can. J. Physiol. Pharmacol., 69, 406–413. Bolli, P., Erne, P., Jr, B. H., Block, L. H., Kiowski, W. and Bühler, F. R. (1983). Adrenaline induces vasoconstriction through postjunctional alpha-2-adrenoceptors and this response is enhanced in patients with essential hypertension. J. Hypertens., 1 (Suppl. 2), 257–259. Bolton, T. B. (1979). Mechanism of action of transmitters and other substances on smooth muscle. Physiol. Rev., 59, 606–718. Bolton, T. B., Clark, J. P., Kitamura, K. and Lang, R. J. (1981). Evidence that histamine and carbachol may open the same ion channels in longitudinal smooth muscle of guinea-pig ileum. J. Physiol., 320, 363–379. Boonen, H. C. and de Mey, J. G. R. (1990). Increased calcium sensitivity in isolated resistance arteries from spontaneously hypertensive rats: effects of dihydropyridines. Eur. J. Pharmacol., 179, 403–412. Borkowski, K. R. (1988). Pre- and postjunctional β-adrenoceptors and hypertension. J. Auton. Pharmacol., 8, 153–171. Bouvier, M. and DE Champlain, J. (1983). Selective activation of the adrenal medulla during acute bilateral carotid occlusion and its modulation by alpha-adrenergic receptor in the rat. Can. J. Physiol. Pharmacol., 61, 381–387. Bouvier, M. and DE Champlain, J. (1986). Effects of acute and chronic administration of sotalol on the blood pressure and the sympathoadrenal activity of anesthetized deoxycorticosterone acetate-salt hypertensive rats. Can. J. Physiol. Pharmacol., 64, 1164–1169. Brehm, P. and Eckert, T. (1978). Calcium entry leads to inactivation of calcium channels in Paramecium. Science, 202, 1203–1206. Broadus, A. E. (1981). Mineral metabolism. In: Endocrinology and Metabolism, pp. 963–1080. Eds P. Felig, J. Baxter, A. E. Broadus and L. Frohman. McGraw-Hill, New York . Brock, T. A., Smith, J. B. and Overbeck, H. W. (1982). Relationship of vascular Na+-K+ pump activity to intracellular sodium in hypertensive rats. Hypertension, 4 (Suppl. II), 43–48. Brogden, R. N., Todd, P. A. and Sorkin, E. M. (1988). Captopril, an update of its pharmaco-dinamic and pharmacokinetic properties and therapeutic use in hypertension and congestive heart failure. Drugs, 36, 540–600. Bruschi, G., Bruschi, M. E., Capelli, P., Regolisti, G. and Borghetti, A. (1988). Increased sensitivity to protein kinase C activation in aortas of spontaneously hypertensive rats. J. Hypertens., 6 (Suppl. 4), 5248–5251. Buckley, J. P., Doursout, M.-F., Liang, Y. Y. and Chelly, J. E. (1986). Central angiotensin II mechanisms and the sodium pump. J. Hypertens., 4 (Suppl. 6), S465–S467. Bühler, F. R. (1990). Calcium antagonists. In: Hypertension: Pathophysiology, Diagnosis, and Management, pp. 2169–2179. Eds J. H. Laragh and B. M. Brenner. Raven Press, New York . Bühler, F. R., Bolli, P., Erne, P., Kiowski, W., Muller, F. B., Hulthén, U. L. and Jr, B. H. (1985). Position of calcium antagonists in antihypertensive therapy. J Cardiovasc. Pharmacol., 7 (Suppl. 4), S21–S27. Bühler, F. R., Hulthén, U. L., Kiowski, W. and Bolli, P. (1982). Greater antihypertensive efficacy of the calcium channel inhibitor verapamil in older and low renin patients. Clin. Sci., 63, 439s–442s. Bühler, F. R., Resink, T. J., Tkachuk, V. A., Zschauer, A., Dimitrov, D., Raine, A. E. G., Bolli, P., Müller, F. B. and Erne, P. (1986). Abnormal cellular calcium regulation in essential hypertension. J. Cardiovasc. Pharmacol., 8 (Suppl. 8), 145–5149. Bukoski, R. D. (1990). Intracellular Ca2+ metabolism of isolated resistance arteries and cultured vascular myocytes of spontaneously hypertensive and Wistar-Kyoto normotensive rats. J. Hypertens., 8, 37–43. Bukoski, R. D., Dewan, P. and Mccarron, D. A. (1988). Intracellular Ca2+ in cultured aortic myocytes and mesenteric resistance vessels of spontaneously hypertensive and Wistar-Kyoto rats. FASEB J., 2, A503. Bukoski, R. D., Xue, H. and Mccarron, D. A. (1987). Effect of 1,25(OH)2 vitamin D3 and ionized Ca2+ on 45Ca uptake by primary cultures of aortic myocytes of spontaneously hypertensive and Wistar Kyoto normotensive rats. Biochem. Biophys. Res. Comm., 146, 1330–1335. Campbell, D. J. (1985). The site of angiotensin production. J. Hypertens., 3, 199–207. Campbell, D. J. (1987). Circulating and tissue angiotensin systems. J. Clin. Invest., 79, 1–6. Cassis, L. A., Stitzel, R. E. and Head, R. J. (1985). Hypernoradrenergic innervation of the caudal artery of the spontaneous hypertensive rat: an influence upon neuroeffector mechanism. J. Pharmacol. exp. Ther., 234, 792–803. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U. and Nishizuka, Y. (1982). Direct activation of calcium-activated, phospholipidid-dependent protein kinase by tumor promoting phorbol esters. J. Biol. Chem., 257, 7847–7851. Cauvin, C. (1985). 45Ca fluxes in mesenteric resistance vessels from spontaneously hypertensive rats. Prog. Appl. Microcirc., 8, 156–165. Cauvin, C., Hwang, B. S., Yammamoto, M. and Van Breemen, C. (1987). Effects of dihydropyridines on tension and calcium-45 influx in isolated mesenteric resistance vessels from spontaneously hypertensive and normotensive rats. Am. J. Cardiol., 59, 116B–122B. Cauvin, C., Loutzenhiser, R. and Van Breemen, C. (1983). Mechanisms of calcium antagonist-induced vasodilation. Ann. Rev. Pharmacol. Tox., 23, 373–396. Cauvin, C. and Van Breemen, C. (1985). Different Ca2+ channels along the arterial tree. J. Cardiovasc. Pharmacol., 7 (Suppl. 4), S4–S10. Chausmer, A. B., Shermar, B. S. and Wallace, S. (1972). The effect of parathyroid hormone in hepatic cell transport of calcium. Endocrinology, 90, 663–672. Chobanian, A. V., Lichtenstein, A. H., Nilakhe, V., Haudenschild, C. C., Drago, R. and Nickerson, C. (1989). Influence of hypertension on aortic atherosclerosis in the Watanabe rabbit. Hypertension, 14, 203–209. Churchill, P. C. (1979). Possible mechanism of the inhibitory effect of ouabain on renin secretion from rat renal cortical slices. J. Physiol., 294, 123–134. Cloix, J. F., Crabos, M., Wainer, I. W., Ruegg, U., Seiler, M. and Meyer, P. (1985). High yield purification of a urinary Na+-pump inhibitor. Biochem. Biophys. Res. Comm., 131, 1234–1240. Clough, D. L., Pamnani, M. B. and Haddy, F. J. (1983). Decreased myocardial Na, K-ATPase activity in one-kidney, one clip hypertensive rat. Am. J. Physiol., 245, H224–H251. Clough, D. L., Pamnani, M. B. and Haddy, F. J. (1984). Myocardial Na, K-ATPase activity in rats with steroid and spontaneous hypertension. J. Hypertens., 2, 141–147. Clozel, M., Kuhn, H., Hefti, F. and Baumgartner, H. R. (1991). Endothelial disfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension, 18, 132–141. Cocks, T. M., Angus, J. A., Campbell, J. H. and Campbell, G. R. (1985). Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture. J. Cell Physiol., 123, 310–320. Cocks, T. M., Angus, J. A., Little, P. J., Campbell, J. H. and Gragoe, E. J. Jr. (1988). Amiloride analogues cause endothelium-dependent relaxation in the canine coronary arteries in vitro: possible role Na+/Ca2+ exchange. Br. J. Pharmacol., 95, 67–76. Colden-Stanfield, M., Schilling, W. P., Ritchie, A. K., Eskin, S. G., Navarro, L. T. and Kunze, D. L. (1987). Bradykinin-induced increases in cytosolic calcium and ionic currents in cultured bovine aortic endothelial cells. Cir. Res., 61, 632–640. Collins, P., Griffith, T. M., Henderson, A. H. and Lewis, M. J. (1986). Endothelium-derived relaxing factor alters calcium fluxes in rabbit aorta: a cyclic guanosine monophosphate-mediated-effect. J. Physiol., 381, 427–437. Cooper, R. S., Shamsi, N. and Katz, S. (1987). Intracellular calcium and sodium in hypertensive patients. Hypertension, 9, 224–229. Corvol, P., Clauser, E. and Waeber, B. (1989). Circulating and tissular renin-angiotensin systems. J. Cardiovasc. Pharmacol., 14 (Suppl. 4), v–vi. Cox, J. A., Comte, M. and Stein, E. A. (1982). Activation of human erythrocyte Ca2+-dependent Mg2+-activate ATPase by calmodulin and calcium: quantitative analysis. Proc. Natl. Acad. Sci. (USA), 79, 4265–4269. Cross, M. F. and Pang, P. K. T. (1980). Parathyroid hormone: a coronary artery vasodilator. Science, 217, 1087–1089. Dahl, L. K., Knudsen, K. D. and Iwai, J. (1969). Humoral transmission of hypertension: evidence from parabiosis. Circ. Res., 24 (Suppl. I), 121–133. Davis, P. W. and Vicenzi, F. F. (1971). Ca-ATPase activation and Na, K-ATPase inhibition as a function of calcium concentration in human red cell membranes. Life Sci., 10, 401–406. De Champlain, J. (1976). Experimental aspects of the relationship between the autonomic nervous system and catecholamines in hypertension. In: Hypertension: Physiopathology and Treatment, pp. 76–92. Eds J. Genest and E. Koiw. McGraw Hill, New York . De Champlain, J. (1990). Pre-and postsynaptic adrenergic dysfunctions in hypertension. J. Hypertens., 8 (Suppl. 7), S77–S85. De Champlain, J., Bouvier, M. and Drolet, G. (1987). Abnormal regulation of the sympathoadrenal system in deoxycorticosterone acetate-salt hypertensive rats. Can. J. Physiol. Pharmacol., 65, 1605–1614. De Champlain, J., Cousineau, D. and Lapointe, L. (1980). Evidence supporting an increased sympathetic tone and reactivity in subgroup of patients with essential hypertension. Clin. Exp. Hypertens., [A] 2, 359–377. De Champlain, J., Eid, H., Bi, Y. J., Le Guerrier, J. and Papin, D. (1990). Enhanced phosphoinoisitide (PI) hydrolysis in cardiovascular tissues during the development of DOCA-salt hypertension. J. Hypertens., 8 (Suppl. 3), S115 (abst). De Champlain, J., Farley, L., Cousineau, D. and Van Amerigen, M.-R. (1976). Circulating catecholamine levels in human and experimental hypertension. Circ. Res., 38, 109–114. De Champlain, J., Krakoff, L. R. and Axelrod, J. (1967). Catecholamine metabolism in experimental hypertension in the cat. Circ. Res., 20, 136–145. De Quattro, V. and Chan, S. (1972). Raised plasma-catecholamines in some patients with primary hypertension. Lancet, i, 806–809. De Wardener, H. E. (1991). Kidney, salt intake, and Na+, K+-ATPase inhibitors in hypertension. Hypertension, 17, 830–836. De Wardener, H. E. and Clarkson, E. M. (1985). Concept of natriuretic hormone. Physiol. Rev., 65, 658–759. De Wardener, H. E. and Macgregor, G. A. (1980). Dahl's hypothesis that a saluretic substance may be responsible for a sustained rise in arterial pressure: its possible role in essential hypertension. Kidney Int., 18, 1–9. De Wardener, H. E. and Macgregor, G. A. (1983). The relation to a circulating transport inhibitor (the natriuretic hormone) to hypertension. Medicine, 62, 310–326. Debinski, W. K. and Kuchel, O. G. (1989). Responsiveness of noradrenergic neurons in rat experimental hypertension. Hypertension, 13, 712–715. Delva, P., Capra, C., Degan, M., Minuz, D., Covi, G., Milan, L., Steele, A. and Lechi, A. (1989). High plasma levels of a ouabain-like factor in normal pregnancy and in preeclampsia. Eur. J. Clin. Invest., 19, 95–100. Derian, C. K. and Moskowitz, M. A. (1986). Polyphosphoinositide hydrolysis in endothelial cells and carotid artery segments. J. Biol. Chem., 261, 3831–3837. Deth, R. and Van Breemen, C. (1977). Agonist induced 45Ca2+ release from smooth muscle cells of the rabbit aorta. J. Membr. Biol., 30, 363–380. Devynck, M. A., Pernollet, M. G., Nunez, A. M. and Meyer, P. (1981a). Analysis of calcium handling in erythrocyte membranes of genetically hypertensive rats. Hypertension, 3, 397–403. Devynck, M. A., Pernollet, M. G., Nunez, A. M. and Meyer, P. (1981b). Calcium binding alteration in plasma membrane from various tissues of spontaneously hypertensive rat. Clin. Exp. Hypertens., 3, 797–807. Devynck, M. A., Pernollet, M. G., Rosenfeld, J. B. and Meyer, P. (1983). Measurement of digitalis like compound in plasma. Application in studies of essential hypertension. Br. Med. J., 287, 631–634. Dong, Y. T. and Wadsworth, R. M. (1986). Effects of drugs that activate or inhibit calcium channels on contraction of the aorta from hypertensive rabbits. J. Cardiovasc. Pharmacol., 8, 1176–1186. Donohue, S. J., Stitzel, R. E. and HEAD, R. J. (1988). Time course of changes in the nor-epinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats. J. Pharmacol. Exp. Ther., 245, 24–31. Drapeau, P. and Blaustein, M. P. (1982). Calcium and neurotransmitter release: what we know and don't know. In: Trends in Autonomic Pharmacology, pp. 117–130. Ed. S. Kalsner. Urban and Schwartzenberg, Baltimore . Dubin, D., Prat, R. E., Cooke, J. P. and Dzau, V. J. (1989). Endothelin, a potent vasoconstrictor, is a vascular smooth muscle mitogen. J. Vase. Med. Biol., 1, 150–154. Dzau, V. J. (1989). Short- and long-term determinants of cardiovascular function and therapy: contributions of circulating and tissue renin-angiotensin systems. J. Casdiovasc. Pharmacol., 14 (Suppl. 4), S1–S5. Edmondson, R. P. S., Thomas, R. D., Hilton, P. J., Patrick, J. and Jones, N. F. (1975). Abnormal leucocyte composition and sodium transport in essential hypertension. Lancet, i, 1003–1005. Ekas, R. D. and Lokhandwala, M. F. (1981). Sympathetic nerve function and vascular reactivity in spontaneously hypertensive rats. Am. J. Physiol., 241, 379–384. Ekas, R. D., Steenberg, M. L. and Lokhandwala, M. F. (1982). Increased presynaptic α-adrenoceptors mediated regulation of noradrenaline release in the isolated perfused kidney of spontaneously hypertensive rats. Clin. Sci., 63 (Suppl. 8), 309s–311s. Endo, T., Naka, M. and Hidaka, H. (1982). Ca2+-phospholipid dependent phosphorylation of smooth muscle myosin. Biochem. Biophys. Res. Comm., 846, 265–274. England, P. J. (1986). Intracellular calcium receptor mechanisms. Br. Med. Bull., 42, 375–383. Engleme, C., Cressier, F. and Wood, J. M. (1990). Local information of angiotensin II in the rat aorta: effect of endothelium. Br. J. Pharmacol., 100, 237–240. Erne, P., Bolli, P., Bertel, O., Hulthén, L., Kowski, W., Müller, F. B. and Bühler, F. (1983). Factors influencing the hypertensive effects of calcium antagonists. Hypertension, 5 (Suppl. II), II97–II102. Erne, P., Bolli, P., Borgisser, E. and Buhler, F. R. (1984). Correlation of platelet calcium with blood pressure: effect of antihypertensive therapy. New Engl. J. Med., 310, 1084–1088. Esler, M. (1987). Biochemical evidence for sympathetic overactivity in human hypertension. In: Behavioral Factors in Hypertension, Handbook of Hypertension, Vol. 9, 75–94. Eds S. Julius and D. R. Bassett. Elsevier, New York . Esler, M., Ferrier, C., Lambert, G., Eisenhofer, G., Cox, H. and Jennings, G. (1991). Biochemical evidence of sympathetic hyperactivity in human hypertension. Hypertension, 17 (Suppl. III), III–29-III-35. Esler, M.. Jackman, G., Bobik, A., Leonard, P., Kelleher, D., Skews, H., Jennings, G. and Korner, P. (1981). Norepine-phrine kinetics in essential hypertension. Defective neuronal uptake of norepinephrine in some patients. Hypertension, 3, 149–156. Fadayomi, M. O., Akinroye, K. K., Ajao, R. O. and Awosika, L. A. (1986). Monotherapy with nifedipine for essential hypertension in adult blacks. J. Cardiovasc. Pharmacol., 8, 466–469. Faraci, F. M. and Heistad, D. D. (1990). Regulation of large cerebral arteries and cerebral microvascular pressure. Circ. Res., 66, 8–17. Feldman, R. D. (1987). β-adrenergic receptor alteration in hypertension: physiological and molecular correlates. Can. J. Physiol. Pharmacol., 64, 1666–1672. Ferrario, C. M. (1990). The renin-angiotensin system: importance in physiology and pathology. J. Cardiovasc. Pharmacol., 15 (Suppl. 3), S1–S5. Fiscus, R. R. (1988). Molecular mechanisms of endothelium-mediated vasodilation. Sem. Thromb. Hemost., 14 (Suppl.), 12–22. Folkow, B. (1982). Physiological aspects of primary hypertension. Physiol. Rev., 62, 347–504. Folkow, B., Hallback, M., Jones, J. V. and Sutter, M. (1977). Dependence on external calcium for the noradrenaline contractility of the resistance vessels in spontaneously hypertensive and renal hypertensive rats as compared to normotensive controls. Acta Physiol. Scand., 101, 84–97. Folsom, A. R., Smith, C. L., Prineas, R. J. and Grim, R. H. (1986). Serum calcium fractions in essential hypertension and matched normotensive control. Hypertension, 8, 11–15. Fray, J. C. S. (1980). Stimulus-secretion coupling of renin: role of hemodynamic and other factors. Circ. Res., 47, 485–492. Fray, J. C. S., Park, C. S. and Valentine, A. N. D. (1987). Calcium and the control of renin secretion. Endocr. Rev., 8, 53–67. Friedman, S. M. (1983a). Cellular ionic pertubations in hypertension. J. Hypertension, 1, 109–114. Friedman, S. M. (1983b). Vascular reactivity. In: Hypertension, 2nd edn, pp. 457–473. Eds J. Genest, O. Kuchel, P. Hamet and M. Cantin. McGraw-Hill, New York . Fronek, K. and Zweifach, B. W. (1975). Micro-vascular pressure distribution in skeletal muscle and the effect of vasodilation. Am. J. Physiol., 228 791–796. Fujimoto, S., Dohi, Y., Aoki, K. and Matsuda, T. (1987). Altered vascular beta adrenoce
Referência(s)